Assenagon Asset Management »

Immunovant shares owned by Assenagon Asset Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Assenagon Asset Management from 13F filings

Historical chart of Assenagon Asset Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Assenagon Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.4M 105k 32.31
2023-12-31 $5.1M 121k 42.13

More positions owned by Assenagon Asset Management

Amazon (AMZN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
Jpmorgan Chase & Co Put Put Option
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Apple Put Put Option
Pdd Holdings Sponsored Ads (PDD)
Intuitive Surgical Com New (ISRG)
Bank America Corp Put Put Option
Citigroup Put Put Option

View all positions for Assenagon Asset Management

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Perceptive Advisors
Armistice Capital
T. Rowe Price Associates
Viking Global Investors
Logos Global Management
Alpine Partners VI
Point72 Asset Management
Geode Capital Management
Woodline Partners
Fred Alger Management
Pictet Asset Management Holding SA
Rock Springs Capital Management

View all funds holding Immunovant